GenovefaAPapanicolaouMD
Infectious Disease • New York, NYProfessor, Medicine, Weill Cornell Medical College
Dr. Papanicolaou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1994 - 1996
Roger Williams Medical CenterFellowship, Infectious Disease, 1993 - 1994
Newton-Wellesley HospitalResidency, Internal Medicine, 1990 - 1993
University of AthensClass of 1985
Certifications & Licensure
NY State Medical License 1996 - 2026
NJ State Medical License 2021 - 2025- American Board of Internal Medicine Infectious Disease
Clinical Trials
- The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections Start of enrollment: 2003 Feb 01
- Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Start of enrollment: 2010 Sep 09
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- AURORA: A New Dawn.Genovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, Rafael F Duarte, Shariq Haider
Clinical Infectious Diseases. 2024-12-17 - 3 citationsBest Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell The...Zainab Shahid, Tania Jain, Veronica Dioverti, Martini Pennisi, Lekha Mikkilineni
Transplantation and Cellular Therapy. 2024-10-01 - Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection.Sunwen Chou, Drew J Winston, Robin K Avery, Catherine Cordonnier, Rafael F Duarte
The Journal of Infectious Diseases. 2024-09-20
Press Mentions
Exploring the Potential of Convalescent Plasma for COVID-19 TreatmentMay 15th, 2020
New Cytomegalovirus Antiviral Shows Efficacy in Phase 3 Clinical TrialJune 22nd, 2017
Grant Support
- Site Specific Integration By Adeno Associated VirusNational Institute Of Allergy And Infectious Diseases2000–2003
- Site Specific Integration By Adeno Associated VirusNational Institute Of Allergy And Infectious Diseases1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
